Protocol Ledger

NCT06096844 · Phase III · RECRUITING

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Interventional Phase III clinical trial protocol NCT06096844 sponsored by National Cancer Institute (NCI) in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-07-19 Enrollment: 304 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06096844
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)304 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06096844
Protocol FieldVerified Registry Value
NCT IdentifierNCT06096844
Consolidated Lead SponsorNational Cancer Institute (NCI)
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment304 participants (ESTIMATED)
Registered Start Date2024-07-19
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06096844
Hospital Research SiteLocationSite Profile
Mercy Hospital Fort SmithFort Smith, AROpen Hospital Dossier ->
UCSF Medical Center and Helen Diller Cancer CenterSan Francisco, CAOpen Hospital Dossier ->
Kaiser Permanente DublinDublin, CAOpen Hospital Dossier ->
Kaiser Permanente-FremontFremont, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI